Ørsted (ORSTED) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
10 Jan, 2026Financial performance and guidance
2024 EBITDA excluding new partnership agreements and cancellation fees is expected at DKK 24.8 billion, matching guidance, driven by stable operational earnings from offshore and onshore assets.
No update provided on 2026 EBITDA target; further details to be shared with full-year results.
Impairments and project challenges
Aggregate impairments of DKK 12.1 billion in Q4 2024 stem from US interest rate hikes, seabed lease revaluations, and Sunrise Wind execution issues.
US interest rate increases led to a 75-basis-point rise in WACC, causing a DKK 4.3 billion impairment for the US portfolio.
Seabed lease impairments off New Jersey, Maryland, and Delaware total DKK 3.5 billion, reflecting market uncertainties and now immaterial on the balance sheet.
Sunrise Wind project delays and cost overruns resulted in a DKK 4.3 billion impairment and commissioning pushed to H2 2027, with challenges including supply chain, vessel, and installation issues.
Project execution and risk management
Installation delays at Sunrise Wind stem from less efficient feeder barge solutions and learnings from Revolution Wind's winter construction.
Majority of the DKK 4.3 billion impairment is cash-effective and will impact CapEx over 2025–2027, with most costs in the latter years.
All necessary vessel charters and federal permits for Sunrise and Revolution Wind are secured, mitigating risk of further major delays.
Project remains profitable with a mid-single-digit life cycle IRR, even if ITC bonus adders are lost, and cancellation is not under consideration.
Project will supply power to nearly 600,000 homes and create hundreds of long-term US jobs.
Latest events from Ørsted
- 2025 EBITDA was DKK 25.1bn; divestments and rights issue drive strong 2026 outlook.ORSTED
Q4 20256 Feb 2026 - Q2 EBITDA up 59% to DKK 5.3bn, driven by offshore wind, with stable 2024 guidance.ORSTED
Q2 20241 Feb 2026 - EBITDA up 22% to DKK 23.6bn, with strong offshore growth and narrowed 2024 guidance.ORSTED
Q3 202416 Jan 2026 - EBITDA hit DKK 32bn, impairments totaled DKK 15.6bn, and 2030 investment plans were cut by 25%.ORSTED
Q4 20249 Jan 2026 - AGM approved all items amid strategic refocus, U.S. challenges, and dividend suspension.ORSTED
AGM 20252 Dec 2025 - EBITDA up 18% and net profit nearly doubled in Q1 2025; renewables at 99% of generation.ORSTED
Q1 202524 Nov 2025 - DKK 60bn rights issue planned as EBITDA rises 10% and profit surges, with 99% renewables.ORSTED
Q2 202523 Nov 2025 - Capital structure strengthened, EBITDA on track, profit hit by impairments, 99% renewables.ORSTED
Q3 20257 Nov 2025 - 2025 EBITDA guidance is DKK 24-27 bn, with investments of DKK 50-54 bn and rising US project risks.ORSTED
Pre-Close Call Presentation9 Oct 2025